Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Hudson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Intellectual & Developmental Disability|December 19, 2012
Father participation with mothers in the Signposts program: an initial investigationFiona S May, Louise A McLean, Angelika Anderson, et al.
Archiv Der Pharmazie|November 16, 2011
N-(Imidazolidin-2-ylidene)-1-arylmethanamine oxides: synthesis, structure and pharmacological evaluationJarosław Saczewski, Alan Hudson, Shayna Laird, et al.
Genomics|October 1, 2015
Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissuesEileen Roulis, Nathan L Bachmann, Garry S A Myers, et al.
Journal of Medicinal Chemistry|July 30, 2008
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functionsFrancesco Gentili, Claudia Cardinaletti, Cristian Vesprini, et al.
European Journal of Medicinal Chemistry|April 1, 2016
Transfer of SAR information from hypotensive indazole to indole derivatives acting at α-adrenergic receptors: In vitro and in vivo studiesJaroslaw Sączewski, Alan Hudson, Mika Scheinin, et al.
Bioorganic & Medicinal Chemistry|December 17, 2011
Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolinesJaroslaw Saczewski, Alan Hudson, Mika Scheinin, et al.
Journal of Medicinal Chemistry|March 23, 2013
Discovery and structure-activity relationships of pyrrolone antimalarialsDinakaran Murugesan, Alka Mital, Marcel Kaiser, et al.
Bioorganic & Medicinal Chemistry|August 31, 2010
Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFIGianfabio Giorgioni, Dario Ambrosini, Cristian Vesprini, et al.
Journal of Medicinal Chemistry|June 8, 2011
Antimalarial pyrido[1,2-a]benzimidazolesAlbert J Ndakala, Richard K Gessner, Patricia W Gitari, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Combined Interactions with I<sub>1</sub>-, I<sub>2</sub>-Imidazoline Binding Sites and α<sub>2</sub>-Adrenoceptors To Manage Opioid AddictionMaria Elena Giusepponi, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Intellectual & Developmental Disability|December 19, 2012
Father participation with mothers in the Signposts program: an initial investigationFiona S May, Louise A McLean, Angelika Anderson, et al.
Archiv Der Pharmazie|November 16, 2011
N-(Imidazolidin-2-ylidene)-1-arylmethanamine oxides: synthesis, structure and pharmacological evaluationJarosław Saczewski, Alan Hudson, Shayna Laird, et al.
Genomics|October 1, 2015
Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissuesEileen Roulis, Nathan L Bachmann, Garry S A Myers, et al.
Journal of Medicinal Chemistry|July 30, 2008
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functionsFrancesco Gentili, Claudia Cardinaletti, Cristian Vesprini, et al.
European Journal of Medicinal Chemistry|April 1, 2016
Transfer of SAR information from hypotensive indazole to indole derivatives acting at α-adrenergic receptors: In vitro and in vivo studiesJaroslaw Sączewski, Alan Hudson, Mika Scheinin, et al.
Bioorganic & Medicinal Chemistry|December 17, 2011
Synthesis and biological activities of 2-[(heteroaryl)methyl]imidazolinesJaroslaw Saczewski, Alan Hudson, Mika Scheinin, et al.
Journal of Medicinal Chemistry|March 23, 2013
Discovery and structure-activity relationships of pyrrolone antimalarialsDinakaran Murugesan, Alka Mital, Marcel Kaiser, et al.
Bioorganic & Medicinal Chemistry|August 31, 2010
Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFIGianfabio Giorgioni, Dario Ambrosini, Cristian Vesprini, et al.
Journal of Medicinal Chemistry|June 8, 2011
Antimalarial pyrido[1,2-a]benzimidazolesAlbert J Ndakala, Richard K Gessner, Patricia W Gitari, et al.
ACS Medicinal Chemistry Letters|October 25, 2016
Combined Interactions with I<sub>1</sub>-, I<sub>2</sub>-Imidazoline Binding Sites and α<sub>2</sub>-Adrenoceptors To Manage Opioid AddictionMaria Elena Giusepponi, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, et al.
Pageof 3